ImmunoMet Therapeutics has a total of 100 patents globally, out of which 67 have been granted. Of these 100 patents, more than 79% patents are active. Parallelly, Korea (South) seems to be the main focused R&D centre and also United States Of America is the origin country of ImmunoMet Therapeutics.
ImmunoMet Therapeutics was founded in 2015. ImmunoMet Therapeutics is a development-stage biotechnology company focused on the development of new oncology treatments to improve the quality of life and make a meaningful difference in the lives of cancer patients.
Do read about some of the most popular patents of ImmunoMet Therapeutics which have been covered by us in this article and also you can find ImmunoMet Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ImmunoMet Therapeutics patent portfolio.
How many patents does ImmunoMet Therapeutics have?
ImmunoMet Therapeutics has a total of 100 patents globally. These patents belong to 27 unique patent families. Out of 100 patents, 79 patents are active.
How Many Patents did ImmunoMet Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | ImmunoMet Therapeutics Applications Filed | ImmunoMet Therapeutics Patents Granted |
| 2023 | 1 | 5 |
| 2022 | 3 | 5 |
| 2021 | 2 | 13 |
| 2020 | 5 | 14 |
| 2019 | 8 | 6 |
| 2018 | 7 | 4 |
| 2017 | 5 | 8 |
| 2016 | 3 | 5 |
| 2015 | 28 | 2 |
| 2014 | 8 | 3 |
| 2013 | 7 | 2 |
| 2012 | 18 | – |
| 2011 | 5 | – |
How many ImmunoMet Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did ImmunoMet Therapeutics File in Different Countries?
Countries in which ImmunoMet Therapeutics Filed Patents
| Country | Patent |
| United States Of America | 22 |
| Korea (South) | 22 |
| Japan | 7 |
| China | 7 |
| Europe | 7 |
| Germany | 6 |
| Hong Kong (S.A.R.) | 5 |
| Austria | 5 |
| India | 4 |
| Spain | 4 |
| Canada | 2 |
| Denmark | 1 |
| Macao | 1 |
Where are Research Centers of ImmunoMet Therapeutics Patents Located?
10 Best ImmunoMet Therapeutics Patents
US20170305861A1 is the most popular patent in the ImmunoMet Therapeutics portfolio. It has received 13 citations so far from companies like Cadent Therapeutics, Incyte Corporation, Nanjing Shijiang Pharmaceutical Technology.
Below is the list of 10 most cited patents of ImmunoMet Therapeutics:
| Publication Number | Citation Count |
| US20170305861A1 | 13 |
| US9133110B2 | 12 |
| US9540325B2 | 9 |
| WO2017188694A1 | 9 |
| CN107108536A | 8 |
| US9321742B2 | 7 |
| US9416098B2 | 6 |
| CN106458868A | 6 |
| US9539238B2 | 4 |
| US9464042B2 | 4 |
What Percentage of ImmunoMet Therapeutics US Patent Applications Were Granted?
ImmunoMet Therapeutics (Excluding its subsidiaries) has filed 19 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 15 have been granted leading to a grant rate of 83.33%.
Below are the key stats of ImmunoMet Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for ImmunoMet Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Clark & Elbing | 17 | 88.24% |
| Lex Ip Meister | 1 | 0% |
| Schwabe Williamson & Wyatt | 1 | 0.00% |
What are Senorics key innovation segments?
What Technologies are Covered by Senorics?
The chart below distributes patents filed by Senorics